162 related articles for article (PubMed ID: 38054798)
1. Discovery of a Highly Potent and Selective MYOF Inhibitor with Improved Water Solubility for the Treatment of Gastric Cancer.
Gu H; Zhang T; Guan T; Wu M; Li S; Li Y; Guo M; Zhang L; Peng Y; Mi D; Liu M; Yi Z; Chen Y
J Med Chem; 2023 Dec; 66(24):16917-16938. PubMed ID: 38054798
[TBL] [Abstract][Full Text] [Related]
2. Discovery of 1,5-diaryl-1,2,4-triazole derivatives as myoferlin inhibitors and their antitumor effects in pancreatic cancer.
Gu H; Zhang T; Li Y; He Y; Guan T; Kan W; He P; Yi Z; Chen Y
Future Med Chem; 2022 Oct; 14(20):1425-1440. PubMed ID: 36165130
[No Abstract] [Full Text] [Related]
3. An Emerging Therapeutic Approach by Targeting Myoferlin (MYOF) for Malignant Tumors.
Gu H; Peng Y; Chen Y
Curr Top Med Chem; 2020; 20(17):1509-1515. PubMed ID: 32552653
[TBL] [Abstract][Full Text] [Related]
4. Loss of myoferlin redirects breast cancer cell motility towards collective migration.
Volakis LI; Li R; Ackerman WE; Mihai C; Bechel M; Summerfield TL; Ahn CS; Powell HM; Zielinski R; Rosol TJ; Ghadiali SN; Kniss DA
PLoS One; 2014; 9(2):e86110. PubMed ID: 24586247
[TBL] [Abstract][Full Text] [Related]
5. Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance.
Harada K; Sakamoto N; Ukai S; Yamamoto Y; Pham QT; Taniyama D; Honma R; Maruyama R; Takashima T; Ota H; Takemoto Y; Tanabe K; Ohdan H; Yasui W
Gastric Cancer; 2021 Nov; 24(6):1264-1277. PubMed ID: 34272617
[TBL] [Abstract][Full Text] [Related]
6. Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancreatic Cancer Metastasis through Targeting Myoferlin.
Li Y; He Y; Shao T; Pei H; Guo W; Mi D; Krimm I; Zhang Y; Wang P; Wang X; Liu M; Yi Z; Chen Y
J Med Chem; 2019 May; 62(10):4949-4966. PubMed ID: 31026162
[TBL] [Abstract][Full Text] [Related]
7. Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP-2 and inducing mesenchymal-to-epithelial transition.
Zhang W; Zhou P; Meng A; Zhang R; Zhou Y
J Cell Mol Med; 2018 Mar; 22(3):1743-1754. PubMed ID: 29164766
[TBL] [Abstract][Full Text] [Related]
8. Myoferlin, a Membrane Protein with Emerging Oncogenic Roles.
Dong Y; Kang H; Liu H; Wang J; Guo Q; Song C; Sun Y; Zhang Y; Zhang H; Zhang Z; Guan H; Fang Z; Li F
Biomed Res Int; 2019; 2019():7365913. PubMed ID: 31828126
[TBL] [Abstract][Full Text] [Related]
9. Myoferlin silencing inhibits VEGFR2-mediated proliferation of metastatic clear cell renal cell carcinoma.
An HJ; Song DH; Koh HM; Kim YM; Ko GH; Lee JH; Lee JS; Yang JW; Kim MH; Seo DH; Jang SM; Kim DC
Sci Rep; 2019 Sep; 9(1):12656. PubMed ID: 31477752
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of Myoferlin Suppresses Migration and Invasion in Clear-Cell Renal-Cell Carcinoma.
Cox A; Zhao C; Tolkach Y; Nettersheim D; Schmidt D; Kristiansen G; Mueller SC; Ritter M; Hauser S; Ellinger J
Anticancer Res; 2020 Jun; 40(6):3119-3128. PubMed ID: 32487606
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic modeling of the effects of myoferlin on tumor cell invasion.
Eisenberg MC; Kim Y; Li R; Ackerman WE; Kniss DA; Friedman A
Proc Natl Acad Sci U S A; 2011 Dec; 108(50):20078-83. PubMed ID: 22135466
[TBL] [Abstract][Full Text] [Related]
12. A small molecule targeting myoferlin exerts promising anti-tumor effects on breast cancer.
Zhang T; Li J; He Y; Yang F; Hao Y; Jin W; Wu J; Sun Z; Li Y; Chen Y; Yi Z; Liu M
Nat Commun; 2018 Sep; 9(1):3726. PubMed ID: 30213946
[TBL] [Abstract][Full Text] [Related]
13. Myoferlin depletion in breast cancer cells promotes mesenchymal to epithelial shape change and stalls invasion.
Li R; Ackerman WE; Mihai C; Volakis LI; Ghadiali S; Kniss DA
PLoS One; 2012; 7(6):e39766. PubMed ID: 22761893
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of Myoferlin in Human Pancreatic Cancer via Bioinformatics.
Pi R; Chen Y; Du Y; Dong S
Biomed Res Int; 2021; 2021():2602322. PubMed ID: 34957301
[TBL] [Abstract][Full Text] [Related]
15. A potent and selective small molecule inhibitor of myoferlin attenuates colorectal cancer progression.
He Y; Kan W; Li Y; Hao Y; Huang A; Gu H; Wang M; Wang Q; Chen J; Sun Z; Liu M; Chen Y; Yi Z
Clin Transl Med; 2021 Feb; 11(2):e289. PubMed ID: 33634965
[TBL] [Abstract][Full Text] [Related]
16. iTRAQ-based quantitative proteomics reveals myoferlin as a novel prognostic predictor in pancreatic adenocarcinoma.
Wang WS; Liu XH; Liu LX; Lou WH; Jin DY; Yang PY; Wang XL
J Proteomics; 2013 Oct; 91():453-65. PubMed ID: 23851313
[TBL] [Abstract][Full Text] [Related]
17. High expression of myoferlin is associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with HPV-status.
Kumar B; Brown NV; Swanson BJ; Schmitt AC; Old M; Ozer E; Agrawal A; Schuller DE; Teknos TN; Kumar P
Oncotarget; 2016 Apr; 7(14):18665-77. PubMed ID: 26919244
[TBL] [Abstract][Full Text] [Related]
18. Acacetin inhibits invasion, migration and TGF-β1-induced EMT of gastric cancer cells through the PI3K/Akt/Snail pathway.
Zhang G; Li Z; Dong J; Zhou W; Zhang Z; Que Z; Zhu X; Xu Y; Cao N; Zhao A
BMC Complement Med Ther; 2022 Jan; 22(1):10. PubMed ID: 35000605
[TBL] [Abstract][Full Text] [Related]
19. Myoferlin depletion elevates focal adhesion kinase and paxillin phosphorylation and enhances cell-matrix adhesion in breast cancer cells.
Blackstone BN; Li R; Ackerman WE; Ghadiali SN; Powell HM; Kniss DA
Am J Physiol Cell Physiol; 2015 Apr; 308(8):C642-9. PubMed ID: 25631868
[TBL] [Abstract][Full Text] [Related]
20. Arborinine, a potential LSD1 inhibitor, inhibits epithelial-mesenchymal transition of SGC-7901 cells and adriamycin-resistant gastric cancer SGC-7901/ADR cells.
Chu Y; Xiao Z; Jing N; Yan W; Wang S; Ma B; Zhang J; Li Y
Invest New Drugs; 2021 Jun; 39(3):627-635. PubMed ID: 33215324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
